Establishment of a Colorectal Cancer-Related MicroRNA-mRNA Regulatory Network by Microarray and Bioinformatics

Dan Jiang1,2, Xiaoliang Xie1,3, Zhenhui Lu1,4

  • 1School of Clinical Medicine, Ningxia Medical University, Yinchuan, China.

Frontiers in Genetics
|November 16, 2020
PubMed

Insights

This study identifies key microRNA-messenger RNA networks involved in colorectal cancer (CRC) development. These findings highlight potential prognostic biomarkers and therapeutic targets for improving CRC patient outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Colorectal cancer (CRC) presents significant global health challenges due to high morbidity and mortality.
  • MicroRNA (miRNA) dysregulation is implicated in CRC pathogenesis, influencing gene expression.
  • Understanding miRNA-mRNA interactions is crucial for identifying novel therapeutic strategies and biomarkers for CRC.

Purpose of the Study:

  • To establish miRNA-mRNA regulatory networks in colorectal cancer.
  • To identify differentially expressed miRNAs (DE miRNAs) and mRNAs (DE mRNAs) in CRC tissues.
  • To explore the potential of identified genes and miRNAs as prognostic biomarkers for CRC.

Main Methods:

  • Microarray assays were employed to screen for DE miRNAs and DE mRNAs in CRC and adjacent normal tissues.
  • Bioinformatic analyses were used to construct miRNA-mRNA networks, protein-protein interaction networks, and identify hub genes.
  • Expression and prognostic potential of selected hub genes were validated.

Main Results:

  • Significant numbers of miRNAs and mRNAs were found to be upregulated and downregulated in CRC tissues.
  • Established miRNA-mRNA networks revealed potential regulatory mechanisms in CRC growth.
  • Hub genes, including CCL-28, GPR15, PNOC, and NUSAP1, along with their interacting miRNAs, showed prognostic potential for CRC patients.

Conclusions:

  • MiRNA-mRNA regulatory networks were successfully constructed for colorectal cancer using microarray data.
  • The identified networks and hub genes offer insights into CRC development mechanisms.
  • Specific miRNA-gene signatures may serve as valuable prognostic and therapeutic targets for CRC.